Company intelligence / Profile preview

API Pharma Tech

Ownership: Private
Employees: ~55
Development stage: Commercial

Overview

API Pharma Tech develops and manufactures both generic and innovative active pharmaceutical ingredients (APIs) as well as finished dosage forms (FDFs), with capabilities from development through to commercial manufacturing. The company emphasizes quality, regulatory compliance, safety, purity, and technological innovation in its operations. It identifies niche/complex APIs for development but does not publicly disclose clinical trial results or proprietary clinical programs.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on API Pharma Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on API Pharma Tech.

Explore the full profile